Current Drug Targets - Inflammation & Allergy is now published as Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy).

Publisher: Bentham Science Publishers

Related content
Volume 1, Number 2, June 2002

< previous issue | all issues | next issue >

Reviews

Favourites:Add to Favourites

The Glucocorticoid Receptor: Molecular Mechanism and New Therapeutic Opportunities
pp. 127-136(10)
Authors: Buckbinder, L.; Robinson, R.P.

Favourites:Add to Favourites

Upstream Signal Transduction of NF-κB Activation
pp. 137-149(13)
Authors: Chen, F.; Demers, L.M.; Shi, X.

Favourites:Add to Favourites

Current and Future Therapeutic Strategies to Target Inflammation in Stroke
pp. 151-166(16)
Authors: Zhang, W.; Stanimirovic, D.

Favourites:Add to Favourites

Mechanisms of Antihistamines and Mast Cell Stabilizers in Ocular Allergic Inflammation
pp. 167-180(14)
Authors: Cook, E.B.; Stahl, J.L.; Barney, N.P.; Graziano, F.M.

Favourites:Add to Favourites

Toll-Like Receptors and Inflammation in the CNS
pp. 181-191(11)
Authors: Joong Lee, S.; Lee, S.

Favourites:Add to Favourites

Cytokines in Dementias
pp. 193-200(8)
Author: Tarkowski, E.

Favourites:Add to Favourites

Eotaxin Receptor (CCR3) Antagonism in Asthma and Allergic Disease
pp. 201-214(14)
Authors: Erin, E.M.; Williams, T.J.; Barnes, P.J.; Hansel, T.T.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more